Post-pandemic Era-Global Cancer Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 254758 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Cancer Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Rophylactic Vaccines -Product Introduction and Major Manufacturers
      1.1.2 Therapeutic Vaccines -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Cancer Vaccines Status and Prospect (2015-2026)
      2.1.1 China Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.1.2 China Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Cancer Vaccines Status and Prospect (2015-2026)
      2.2.1 EU Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.2.2 EU Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Cancer Vaccines Status and Prospect (2015-2026)
      2.3.1 USA Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.3.2 USA Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Cancer Vaccines Status and Prospect (2015-2026)
      2.4.1 Japan Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Cancer Vaccines Status and Prospect (2015-2026)
      2.5.1 India Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.5.2 India Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Cancer Vaccines Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Cancer Vaccines Status and Prospect (2015-2026)
      2.7.1 South America Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.7.2 South America Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Cancer Vaccines Status and Prospect (2015-2026)
      2.8.1  Cancer Vaccines Market Size and Growth Rate (2015-2026)
      2.8.2  Cancer Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Cancer Vaccines Market Assessment by Segment
    3.1 Global Cancer Vaccines Capacity and Growth Rate
    3.2 Global Cancer Vaccines Sales by Type
    3.3 Global Cancer Vaccines Sales Revenue by Type
    3.4 Global Cancer Vaccines Consumption by Application
4 Global Cancer Vaccines Market Assessment by Regions
    4.1 Global Cancer Vaccines Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Cancer Vaccines Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Cancer Vaccines Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Cancer Vaccines Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Cancer Vaccines Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Cancer Vaccines Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Cancer Vaccines Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Cancer Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)

7 Cancer Vaccines Competitive Analysis
     7.1 Dendreon
        7.1.1 Dendreon Company Profiles
        7.1.2 Dendreon Product Introduction
        7.1.3 Dendreon Cancer Vaccines Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Profiles
        7.2.2 GlaxoSmithKline Product Introduction
        7.2.3 GlaxoSmithKline Cancer Vaccines Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Merck
        7.3.1 Merck Company Profiles
        7.3.2 Merck Product Introduction
        7.3.3 Merck Cancer Vaccines Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Sanofi
        7.4.1 Sanofi Company Profiles
        7.4.2 Sanofi Product Introduction
        7.4.3 Sanofi Cancer Vaccines Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 Amgen
        7.5.1 Amgen Company Profiles
        7.5.2 Amgen Product Introduction
        7.5.3 Amgen Cancer Vaccines Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Biothera
        7.6.1 Biothera Company Profiles
        7.6.2 Biothera Product Introduction
        7.6.3 Biothera Cancer Vaccines Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Isa Pharmaceuticals
        7.7.1 Isa Pharmaceuticals Company Profiles
        7.7.2 Isa Pharmaceuticals Product Introduction
        7.7.3 Isa Pharmaceuticals Cancer Vaccines Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Bristol-Myers Squibb
        7.8.1 Bristol-Myers Squibb Company Profiles
        7.8.2 Bristol-Myers Squibb Product Introduction
        7.8.3 Bristol-Myers Squibb Cancer Vaccines Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
     7.9 Bavarian Nordic
        7.9.1 Bavarian Nordic Company Profiles
        7.9.2 Bavarian Nordic Product Introduction
        7.9.3 Bavarian Nordic Cancer Vaccines Production, Revenue (2015-2020)
        7.9.4 SWOT Analysis
     7.10 Antigen Express
        7.10.1 Antigen Express Company Profiles
        7.10.2 Antigen Express Product Introduction
        7.10.3 Antigen Express Cancer Vaccines Production, Revenue (2015-2020)
        7.10.4 SWOT Analysis
     7.11 Juvaris Biotherapeutics
     7.12 Provectus Biopharmaceuticals
     7.13 Aduro BioTech
     7.14 Galena Biopharma
     7.15 Northwest Biotherapeutics
     7.16 Oxford BioMedica
     7.17 Inovio Pharmaceuticals
     7.18 Vaxon Biotech
     7.19 Celldex Therapeutics
     7.20 Prima BioMed
8 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Cancer Vaccines Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Cancer Vaccines Sales (K Unit) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Cancer Vaccines Sales Market Share (%) by Type (2019 -2020)
    Table Global Cancer Vaccines Sales Value (Million USD) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Cancer Vaccines Sales Value Market Share (%) by Type (2019-2020)
    Table Global Cancer Vaccines Sales (K Unit) by Application (2015-2026)
    Figure China Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Cancer Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Cancer Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Cancer Vaccines Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Cancer Vaccines Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Cancer Vaccines Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Cancer Vaccines Consumption (Unit) by Application (2015-2026)
    Figure Global Cancer Vaccines Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Cancer Vaccines Production (K Unite) by Regions (2015-2020)
    Table Global Cancer Vaccines CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Cancer Vaccines Production Share by Regions (2019-2020)
    Table Global Cancer Vaccines Sales (K Unite) by Regions (2015-2020)
    Table Global Cancer Vaccines CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Cancer Vaccines Sales Share by Regions (2019-2020)
    Table Global Cancer Vaccines Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Cancer Vaccines CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Cancer Vaccines Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Cancer Vaccines
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Cancer Vaccines
    Figure Cost Structure of Cancer Vaccines in 2020
    Table Global Cancer Vaccines Capacity Share of Manufacturers (2019-2020)
    Figure Global Cancer Vaccines Capacity Share of Manufacturers (2019-2020)
    Table Global Cancer Vaccines Sales Market Share of Manufacturers (2019-2020)
    Figure Global Cancer Vaccines Sales Market Share of Manufacturers (2019-2020)
    Table Global Cancer Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Cancer Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Cancer Vaccines Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Dendreon Profiles
    Table Dendreon Cancer Vaccines Product Introduction
    Table Dendreon Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Dendreon SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Cancer Vaccines Product Introduction
    Table GlaxoSmithKline Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table Merck Profiles
    Table Merck Cancer Vaccines Product Introduction
    Table Merck Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Merck SWOT Analysis
    Table Sanofi Profiles
    Table Sanofi Cancer Vaccines Product Introduction
    Table Sanofi Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Sanofi SWOT Analysis
    Table Amgen Profiles
    Table Amgen Cancer Vaccines Product Introduction
    Table Amgen Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Amgen SWOT Analysis
    Table Biothera Profiles
    Table Biothera Cancer Vaccines Product Introduction
    Table Biothera Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Biothera SWOT Analysis
    Table Isa Pharmaceuticals Profiles
    Table Isa Pharmaceuticals Cancer Vaccines Product Introduction
    Table Isa Pharmaceuticals Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Isa Pharmaceuticals SWOT Analysis
    Table Bristol-Myers Squibb Profiles
    Table Bristol-Myers Squibb Cancer Vaccines Product Introduction
    Table Bristol-Myers Squibb Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Bristol-Myers Squibb SWOT Analysis
    Table Bavarian Nordic Profiles
    Table Bavarian Nordic Cancer Vaccines Product Introduction
    Table Bavarian Nordic Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Bavarian Nordic SWOT Analysis
    Table Antigen Express Profiles
    Table Antigen Express Cancer Vaccines Product Introduction
    Table Antigen Express Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Antigen Express SWOT Analysis
    Table Juvaris Biotherapeutics Profiles
    Table Juvaris Biotherapeutics Cancer Vaccines Product Introduction
    Table Juvaris Biotherapeutics Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Juvaris Biotherapeutics SWOT Analysis
    Table Provectus Biopharmaceuticals Profiles
    Table Provectus Biopharmaceuticals Cancer Vaccines Product Introduction
    Table Provectus Biopharmaceuticals Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Provectus Biopharmaceuticals SWOT Analysis
    Table Aduro BioTech Profiles
    Table Aduro BioTech Cancer Vaccines Product Introduction
    Table Aduro BioTech Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Aduro BioTech SWOT Analysis
    Table Galena Biopharma Profiles
    Table Galena Biopharma Cancer Vaccines Product Introduction
    Table Galena Biopharma Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Galena Biopharma SWOT Analysis
    Table Northwest Biotherapeutics Profiles
    Table Northwest Biotherapeutics Cancer Vaccines Product Introduction
    Table Northwest Biotherapeutics Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Northwest Biotherapeutics SWOT Analysis
    Table Oxford BioMedica Profiles
    Table Oxford BioMedica Cancer Vaccines Product Introduction
    Table Oxford BioMedica Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Oxford BioMedica SWOT Analysis
    Table Inovio Pharmaceuticals Profiles
    Table Inovio Pharmaceuticals Cancer Vaccines Product Introduction
    Table Inovio Pharmaceuticals Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Inovio Pharmaceuticals SWOT Analysis
    Table Vaxon Biotech Profiles
    Table Vaxon Biotech Cancer Vaccines Product Introduction
    Table Vaxon Biotech Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Vaxon Biotech SWOT Analysis
    Table Celldex Therapeutics Profiles
    Table Celldex Therapeutics Cancer Vaccines Product Introduction
    Table Celldex Therapeutics Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Celldex Therapeutics SWOT Analysis
    Table Prima BioMed Profiles
    Table Prima BioMed Cancer Vaccines Product Introduction
    Table Prima BioMed Cancer Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Prima BioMed SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Cancer Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Cancer Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Cancer Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports